Company Overview and News
Chimeric antigen receptor T-cell receptor (CAR-T) and CAR-modified natural killer (CAR-NK) therapeutics can be produced faster and at less cost, Cesca Therapeutics says, through the cellular processing technology covered by a recently-awarded patent.
LONDON, UK / ACCESSWIRE / July 31, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Cesca Therapeutics Inc. (NASDAQ: KOOL) ("Cesca"), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=KOOL. The Company, which is a market leader in automated cell processing, announced on July 28, 2017, that the US Patent and Trademark Office has awarded a new US Patent (the ‘394 patent'), entitled Cell Separation Devices, Systems, and Methods to SynGen, Inc.
LONDON, UK / ACCESSWIRE / July 12, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for Cesca Therapeutics Inc. (NASDAQ: KOOL), following which we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/?symbol=KOOL. The Company announced on July 10, 2017, that its wholly-owned subsidiary, ThermoGenesis Corp., has entered into an asset acquisition agreement with SynGen, Inc.
• Shares of Hawaiian Telcom Holdco, Inc. surged 18.1% following news that Cincinnati Bell (CBB - Free Report) has decided to acquire the company for $650 million • Cesca Therapeutics Inc's soared 16.9% after the company purchased SynGen Inc.’s cell processing systems • Shares of ClubCorp Holdings, Inc. (MYCC - Free Report) skyrocketed 30.2% following news that Apollo Global Management (APO - Free Report) has agreed to acquire the company for $1.
WASHINGTON, DC--(Marketwired - May 9, 2017) - The Alliance for Regenerative Medicine (ARM) today released the agenda for the inaugural Cell & Gene Exchange, the only partnering conference that brings together the regulatory, business and patient advocacy communities across the cell and gene therapy sectors. Co-produced by ARM and EBD Group and held in partnership with Global Genes, the event will take place May 22 and 23 in Washington, D.
The Coal Ministry has slapped a show cause notice on GMR for delay in payment with regard to Talabira coal mine in Odisha. The successful bidder is required to make monthly payments within 20 calendar days of expiry of each month with respect to coal extracted from the coal mine in such calendar month. In a letter dated March 11 to the Chairman of GMR Chhattisgarh, the Ministry said there was a delay in payment for the months of August 2015 and January 2016.
Utilities have reported adj. PAT growth of 30% for 9MFY16; cost reductions likely to continue driving profitability for the sector
Market turns range bound
A day in the lives of a corporate tycoon, a startup CEO and a jewellery magnate
Sales up 23, net up 1%
Compared with net profit of Rs111 crore in third quarter of last fiscal, CESC net profit remained stagnant at Rs112 crore during the quarter under review
Our regular result provides commentary on the company’s quarterly results for the viewers. The company’s standalone revenue stood at Rs. 1,538 crore, up by 23.14% yoy but down by 13.21% qoq.
Total Income has increased from Rs. 12700 mn for the quarter ended December 31, 2014 to Rs. 15810 million for the quarter ended December 31, 2015.
Bharti Airtel | Idea Cellular | Dr Reddy's Labs | Hindalco Industries | Entertainment Network | Gujarat Gas | SPML Infra | GSK Consumer | TV Today | Atul Auto | Narayana Hrudayalaya | JK Tyre and SRF are stocks, which are in the news today...
2017-12-11 - Wilton
2017-12-11 - Wilton
2017-12-03 - Wilton
2017-11-27 - Wilton